Career history of Norman L. Halleen
Former positions of Norman L. Halleen
Companies | Position | Start | End |
---|---|---|---|
ARADIGM CORPORATION | Director of Finance/CFO | 1999-11-30 | 2008-09-21 |
INTERMUNE INC | Director of Finance/CFO | 2004-09-30 | 2006-07-27 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Director of Finance/CFO | 2001-03-31 | 2003-05-31 |
Collagen Corp. | Director of Finance/CFO | 1996-12-31 | 1999-09-30 |
Training of Norman L. Halleen
Stanford University | Undergraduate Degree |
Harvard University | Masters Business Admin |
Statistics
International
United States | 7 |
Operational
Director of Finance/CFO | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Collagen Corp. | Health Technology |
- Stock Market
- Insiders
- Norman L. Halleen
- Experience